High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients.

AIDS
Claudia PinacchioGabriella d'Ettorre

Abstract

HIV-1-associated dysbiosis is most commonly characterized by overall decreased diversity, with abundance of the genus Prevotella, recently related to inflammatory responses. A pilot study including 10 antiretroviral therapy-treated HIV-1-infected men and 50 uninfected controls was performed to identify the main gut dysbiosis determinants (e.g. Prevotella enrichment), that may affect mucosal antiviral defenses and T cell immunity in HIV-1-infected individuals. 16rRNA gene sequencing was applied to the HIV-1-infected individuals' fecal microbiota and compared with controls. Measurements of CD4 and CD8 T cell activation [CD38, human leukocyte antigen (HLA)-DR, CD38 HLA-DR] and frequencies of Th17, obtained from lamina propria lymphocytes isolated from five different intestinal sites, were performed by flow cytometry. IFNβ, IFNAR1 and MxA gene expression level was evaluated by real-time PCR in lamina propria lymphocytes. Nonparametric t tests were used for statistical analysis. HIV-1-infected men had a significant fecal microbial communities' imbalance, including different levels of genera Faecalibacterium, Prevotella, Alistipes and Bacteroides, compared with controls. Notably, Prevotella abundance positively correlated with freque...Continue Reading

References

Apr 24, 2003·Journal of Dental Research·P S KumarE J Leys
Apr 6, 2006·Journal of Medical Microbiology·Katja LuckeMarkus Schuppler
Jun 15, 2010·Current Opinion in HIV and AIDS·Aimee Elhed, Derya Unutmaz
Aug 4, 2010·Proceedings of the National Academy of Sciences of the United States of America·Carlotta De FilippoPaolo Lionetti
Apr 22, 2011·Nature·Manimozhiyan ArumugamPeer Bork
Jun 13, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stephanie M DillonCara C Wilson
Jul 12, 2013·Science Translational Medicine·Ivan Vujkovic-CvijinJoseph M McCune
Sep 17, 2013·Cell Host & Microbe·Catherine A LozuponeBrent E Palmer
Sep 12, 2015·AIDS·Piotr NowakAnders Sönnerborg
Mar 8, 2016·Cellular Microbiology·Brett WilliamsRachel M Presti
Aug 23, 2016·BMJ Open Gastroenterology·Grégory DubourgDidier Raoult
Oct 19, 2016·AIDS·Stephanie M DillonCara C Wilson
Jan 11, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jay LiuAlan L Landay
Mar 27, 2018·Cytokine & Growth Factor Reviews·Carolina Scagnolari, Guido Antonelli
Apr 14, 2018·EBioMedicine·Charles Preston NeffBrent E Palmer
Sep 12, 2018·The Journal of Infectious Diseases·Jan KehrmannUNKNOWN HIV-HEART Study Group
Dec 20, 2018·Medical Microbiology and Immunology·Maura StatzuCarolina Scagnolari
Jun 14, 2019·Frontiers in Microbiology·Katti R Crakes, Guochun Jiang
Dec 4, 2019·Current Opinion in Infectious Diseases·Dag Henrik ReikvamBirgitte Stiksrud

❮ Previous
Next ❯

Citations

Mar 10, 2021·Current HIV/AIDS Reports·Stephanie M Dillon, Cara C Wilson
Jun 17, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laura E MartínezMarta Epeldegui

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.